Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Lafitte

Showing results (121-130 of 152) with videos related to

Pageof 16
Sort By:
Pharmacogenetics|March 25, 1998
Cytochrome P450 CYP2D6 gene polymorphism and lung cancer susceptibility in CaucasiansM Legrand-Andréoletti, I Stücker, D Marez, et al.
Revue Des Maladies Respiratoires|December 11, 2002
[VEGF and survival of patients with lung cancer: a systematic literature review and meta-analysis]P Delmotte, B Martin, M Paesmans, et al.
The European Respiratory Journal|November 5, 2002
The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysisA P Meert, B Martin, P Delmotte, et al.
American Journal of Respiratory and Critical Care Medicine|May 6, 1999
Increased glucocorticoid receptor beta in airway cells of glucocorticoid-insensitive asthmaQ A Hamid, S E Wenzel, P J Hauk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2002
A phase II randomised trial comparing the cisplatin-etoposide combination chemotherapy with or without carboplatin as second-line therapy for small-cell lung cancerJ P Sculier, J J Lafitte, J Lecomte, et al.
British Journal of Cancer|May 5, 2001
The role of mitomycin in the treatment of non-small cell lung cancer: a systematic review with meta-analysis of the literatureJ P Sculier, L Ghisdal, T Berghmans, et al.
Lung Cancer (Amsterdam, Netherlands)|June 19, 2012
Final results and pharmacoeconomic analysis of a trial comparing two neoadjuvant chemotherapy (CT) regimens followed by surgery in patients with resectable non-small cell lung cancer (NSCLC): a phase II randomised study by the European Lung Cancer Working PartyT Berghmans, J J Lafitte, V Giner, et al.
Revue Des Maladies Respiratoires|December 25, 2008
[Characteristics of the patients included in the French cohort of patients with emphysema caused by alpha-1 antitrypsin deficiency]G Thabut, J-F Mornex, A Cuvelier, et al.
British Journal of Cancer|December 15, 2004
The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysisC Mascaux, N Iannino, B Martin, et al.
The European Respiratory Journal|June 10, 2010
Valproate-doxorubicin: promising therapy for progressing mesothelioma. A phase II studyA Scherpereel, T Berghmans, J J Lafitte, et al.
Pageof 16

Showing results (121-130 of 152) with videos related to

Sort By:
Pageof 16
Pharmacogenetics|March 25, 1998
Cytochrome P450 CYP2D6 gene polymorphism and lung cancer susceptibility in CaucasiansM Legrand-Andréoletti, I Stücker, D Marez, et al.
Revue Des Maladies Respiratoires|December 11, 2002
[VEGF and survival of patients with lung cancer: a systematic literature review and meta-analysis]P Delmotte, B Martin, M Paesmans, et al.
The European Respiratory Journal|November 5, 2002
The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysisA P Meert, B Martin, P Delmotte, et al.
American Journal of Respiratory and Critical Care Medicine|May 6, 1999
Increased glucocorticoid receptor beta in airway cells of glucocorticoid-insensitive asthmaQ A Hamid, S E Wenzel, P J Hauk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2002
A phase II randomised trial comparing the cisplatin-etoposide combination chemotherapy with or without carboplatin as second-line therapy for small-cell lung cancerJ P Sculier, J J Lafitte, J Lecomte, et al.
British Journal of Cancer|May 5, 2001
The role of mitomycin in the treatment of non-small cell lung cancer: a systematic review with meta-analysis of the literatureJ P Sculier, L Ghisdal, T Berghmans, et al.
Lung Cancer (Amsterdam, Netherlands)|June 19, 2012
Final results and pharmacoeconomic analysis of a trial comparing two neoadjuvant chemotherapy (CT) regimens followed by surgery in patients with resectable non-small cell lung cancer (NSCLC): a phase II randomised study by the European Lung Cancer Working PartyT Berghmans, J J Lafitte, V Giner, et al.
Revue Des Maladies Respiratoires|December 25, 2008
[Characteristics of the patients included in the French cohort of patients with emphysema caused by alpha-1 antitrypsin deficiency]G Thabut, J-F Mornex, A Cuvelier, et al.
British Journal of Cancer|December 15, 2004
The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysisC Mascaux, N Iannino, B Martin, et al.
The European Respiratory Journal|June 10, 2010
Valproate-doxorubicin: promising therapy for progressing mesothelioma. A phase II studyA Scherpereel, T Berghmans, J J Lafitte, et al.
Pageof 16